In another recent study, it was reported that hsa_circ_0004015 was highly expressed in non-small cell lung cancer (NSCLC) which significantly contributes to disease progression and EGFR-Tyrosine Kinase Inhibitors (TKI) resistance (Zhou et al., 2019). This evidence concerns the gene EGFR and non-small cell lung carcinoma.